Fluoxetine for Hot Flashes
Fluoxetine can help reduce hot flashes with a modest effect, decreasing hot flash composite scores by approximately 50% versus 36% for placebo in breast cancer patients, though with significant variability in response and limited long-term efficacy. 1
Efficacy of Fluoxetine for Hot Flashes
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), has demonstrated effectiveness for managing menopausal hot flashes in short-term studies:
- In breast cancer patients, fluoxetine decreased hot flash composite scores by 50% versus 36% for placebo 1
- Response variability is significant:
- 42% of patients improved by >50%
- 30% improved by <50%
- 27% experienced worsening of hot flashes 1
Limitations and Considerations
Several important limitations should be noted:
- Long-term efficacy is questionable - one study reported that at 9 months, fluoxetine was not superior to placebo for vasomotor symptoms 1
- Gabapentin (300 mg/day) has been shown to be more effective than fluoxetine (20 mg/day) for treating vasomotor symptoms in postmenopausal women 2
- When compared to other options, fluoxetine should be considered a second or third-line option after venlafaxine or paroxetine based on available evidence 3
Side Effects and Precautions
Common side effects of fluoxetine when used for hot flashes include:
- Headache
- Nausea
- Reduced appetite
- Gastrointestinal disturbance
- Dry mouth
- Anxiety/agitation
- Sleep disturbance
- Sexual dysfunction 1
Most side effects are mild and short-lived, but adverse events cause 10-20% of individuals to withdraw from treatment 1.
Important Drug Interaction Warning
Fluoxetine is a potent inhibitor of CYP2D6 and should be avoided in breast cancer patients taking tamoxifen, as it may interfere with tamoxifen metabolism to its active form, potentially reducing its effectiveness 1.
Alternative Options
If fluoxetine is ineffective or poorly tolerated, consider:
First-line alternatives:
Other options:
Practical Prescribing Approach
- Start with fluoxetine 20 mg daily
- Evaluate response after 4-6 weeks
- If inadequate response or intolerable side effects, consider switching to venlafaxine or paroxetine
- Taper gradually when discontinuing to prevent withdrawal symptoms
Remember that the clinical efficacy of SSRIs for hot flashes appears modest compared with estrogen therapy, though direct head-to-head studies are lacking 1.